论著

苯并[a]芘对神经胶质细胞中胰岛素降解酶与脑啡肽酶表达的影响

  • 张慧峰 ,
  • 黄焕焕 ,
  • 赵雨佳 ,
  • 李清如 ,
  • 祁宇泽 ,
  • 周辉
展开
  • (北京大学公共卫生学院劳动卫生与环境卫生学系, 北京100191)

网络出版日期: 2018-06-18

基金资助

 国家自然科学基金(21577004)和北京市自然科学基金(7162104)资助

Effects of benzo(a)pyrene on expressions of insulin-degrading enzyme and neprilysin in neuroglia cells

  • ZHANG Hui-feng ,
  • HUANG Huan-huan ,
  • ZHAO Yu-jia ,
  • LI Qing-ru ,
  • QI Yu-ze ,
  • ZHOU Hui
Expand
  • (Department of Occupational and Environmental Health, Peking University School of Public Health, Beijing 100191, China)

Online published: 2018-06-18

Supported by

Supported by the National Natural Science Foundation of China (21577004) and the Natural Science Foundation of Beijing (7162104)

摘要

目的:探讨苯并[a]芘[benzo(a)pyrene,BaP]对神经胶质细胞中具有β-淀粉体(β-amyloid,Aβ)清除作用的胰岛素降解酶(insulin-degrading enzyme,IDE)及脑啡肽酶(neprilysin,NEP)表达的影响。方法:制备新生SD大鼠原代神经胶质细胞混合培养体系,接受不同浓度的BaP、Aβ1-42寡聚体、Aβ1-42纤维体单独或联合处理24 h后,采用细胞增殖毒性检测试剂盒测定细胞存活率。随机分为对照组、BaP(2.00 μmol/L)组、Aβ1-42(20.00 mg/L)寡聚体组、BaP+Aβ1-42寡聚体组、Aβ1-42(20.00 mg/L)纤维体组、BaP+Aβ1-42纤维体组,其中BaP均为预处理12 h后再与不同聚集状态的Aβ1-42共同作用。进一步采用实时荧光定量PCR及蛋白质免疫印迹技术检测体系中IDE、NEP的mRNA和蛋白表达水平。结果:20.00 μmol/L及以下浓度的BaP处理,20.00、40.00 mg/L的Aβ1-42寡聚体或Aβ1-42纤维体单独处理,BaP与Aβ1-42寡聚体或BaP与Aβ1-42纤维体联合处理对神经胶质细胞的存活率均无明显影响。与对照组相比,BaP单独处理组中IDE、NEP的mRNA和蛋白水平均未明显改变;而Aβ1-42寡聚体单独作用可明显上调IDE的mRNA及蛋白水平(P<0.05),同时BaP预处理可显著抑制Aβ1-42寡聚体作用引起的IDE表达水平上调(P<0.05);另一方面,Aβ1-42纤维体在单独处理或有BaP预处理情况下,IDE、NEP的mRNA和蛋白水平均未发生明显改变。结论:在对细胞存活率无明显影响的前提下,BaP预处理显著抑制了Aβ寡聚体作用后的IDE表达水平上调,提示苯并[a]芘可能干扰Aβ寡聚体降解途径导致Aβ增多聚集,进而可能促进认知功能降低及阿尔兹海默病的形成。

本文引用格式

张慧峰 , 黄焕焕 , 赵雨佳 , 李清如 , 祁宇泽 , 周辉 . 苯并[a]芘对神经胶质细胞中胰岛素降解酶与脑啡肽酶表达的影响[J]. 北京大学学报(医学版), 2018 , 50(3) : 401 -407 . DOI: 10.3969/j.issn.1671-167X.2018.03.003

Abstract

Objective: To investigate effects of benzo(a)pyrene (BaP) on expressions of insulin-degrading enzyme (IDE) and neprilysin (NEP) which have the ability to degrade β-amyloid (Aβ) in neu-roglia cells. Methods: Primary mix-neuroglia cells were cultured from newborn SD rats. After exposure to BaP, Aβ1-42 oligomer or Aβ1-42 fiber individually or jointly for 24 h, the cell survival rate was mea-sured by cell counting kit-8 (CCK-8). Afterwards, the primary mix-neuroglia cells were divided randomly into six groups: Control group, BaP group (2.00 μmol/L), Aβ1-42 oligomer group (20.00 mg/L), BaP plus Aβ1-42 oligomer group, Aβ1-42 fiber group (20.00 mg/L) and BaP plus Aβ1-42 fiber group, of which BaP was pretreated for 12 h followed by cotreatment with different aggregated Aβ1-42. The expressions of IDE and NEP were measured by quantitative real-time polymerase chain reaction (qRT-PCR) for mRNA level and Western blotting for protein level. Results: The cell survival rate showed no significant differences after treatment with BaP (≤20.00 μmol/L), Aβ1-42 oligomer (20.00, 40.00 mg/L), Aβ1-42 fiber (20.00, 40.00 mg/L) or cotreatment with BaP and Aβ1-42 oligomer or BaP and Aβ1-42 fiber. Compared with the control group, expressions of IDE and NEP in BaPtreated alone group had no obvious change; however, exposure to Aβ1-42 oligomer alone significantly increased the mRNA and protein level of IDE (P<0.05), and the BaP pretreatment could significantly inhibit the up-regulated expressions of IDE by Aβ1-42 oligomer (P<0.05); on the other hand, exposure either to Aβ1-42 fiber alone or under the BaP pretreatment did not change the mRNA and protein level of IDE and NEP obviously. Conclusion: On the premise of no significant change of cell survival rate, BaP pretreatment inhibited the up-regulated expressions of IDE in primary mixed neuroglia cells under cotreatment with Aβ oligomer, indicating that BaP may disturb degradation of Aβ oligomer and cause deposition of β-amyloid and further induce cognitive decline and acceleration of Alzheimer.
文章导航

/